Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 8
Results: 38
The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β‐catenin signaling.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2642, doi. 10.1111/cas.15467
- By:
- Publication type:
- Article
Hippo pathway monomerizes STAT3 to regulate prostate cancer growth.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2753, doi. 10.1111/cas.15463
- By:
- Publication type:
- Article
Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
- By:
- Publication type:
- Article
High levels of chromosomal instability facilitate the tumor growth and sphere formation.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2727, doi. 10.1111/cas.15457
- By:
- Publication type:
- Article
Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2849, doi. 10.1111/cas.15456
- By:
- Publication type:
- Article
Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2839, doi. 10.1111/cas.15455
- By:
- Publication type:
- Article
ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2738, doi. 10.1111/cas.15454
- By:
- Publication type:
- Article
CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2704, doi. 10.1111/cas.15452
- By:
- Publication type:
- Article
Therapeutic advantage of targeting lysosomal membrane integrity supported by lysophagy in malignant glioma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2716, doi. 10.1111/cas.15451
- By:
- Publication type:
- Article
A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2798, doi. 10.1111/cas.15450
- By:
- Publication type:
- Article
H1.0 induces paclitaxel‐resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2616, doi. 10.1111/cas.15448
- By:
- Publication type:
- Article
Comprehensive network analysis of dysregulated genes revealed MNX1‐AS1/hsa‐miR‐4697‐3p/HOXB13 axis in ovarian cancer chemotherapy response.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2627, doi. 10.1111/cas.15447
- By:
- Publication type:
- Article
Biological effectiveness and relative biological effectiveness of ion beams for in‐vitro cell irradiation.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2807, doi. 10.1111/cas.15446
- Publication type:
- Article
AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2600, doi. 10.1111/cas.15445
- By:
- Publication type:
- Article
Prosaposin, tumor‐secreted protein, promotes pancreatic cancer progression by decreasing tumor‐infiltrating lymphocytes.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2548, doi. 10.1111/cas.15444
- By:
- Publication type:
- Article
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2788, doi. 10.1111/cas.15443
- By:
- Publication type:
- Article
A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2526, doi. 10.1111/cas.15429
- By:
- Publication type:
- Article
Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2862, doi. 10.1111/cas.15440
- By:
- Publication type:
- Article
27‐Hydroxycholesterol promotes metastasis by SULT2A1‐dependent alteration in hepatocellular carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2575, doi. 10.1111/cas.15435
- By:
- Publication type:
- Article
A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2536, doi. 10.1111/cas.15434
- By:
- Publication type:
- Article
Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2778, doi. 10.1111/cas.15431
- By:
- Publication type:
- Article
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2590, doi. 10.1111/cas.15441
- By:
- Publication type:
- Article
Label‐free multiphoton excitation imaging as a promising diagnostic tool for breast cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2916, doi. 10.1111/cas.15428
- By:
- Publication type:
- Article
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2763, doi. 10.1111/cas.15427
- By:
- Publication type:
- Article
CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR‐33a/b to disinhibit PD‐L1.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2888, doi. 10.1111/cas.15402
- By:
- Publication type:
- Article
Development of a potent small‐molecule degrader against oncogenic BRAF<sup>V600E</sup> protein that evades paradoxical MAPK activation.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2828, doi. 10.1111/cas.15401
- By:
- Publication type:
- Article
Oxidized high mobility group B‐1 enhances metastability of colorectal cancer via modification of mesenchymal stem/stromal cells.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2904, doi. 10.1111/cas.15400
- By:
- Publication type:
- Article
HDAC5, negatively regulated by miR‐148a‐3p, promotes colon cancer cell migration.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2560, doi. 10.1111/cas.15399
- By:
- Publication type:
- Article
IFN‐α/β‐mediated NK2R expression is related to the malignancy of colon cancer cells.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2513, doi. 10.1111/cas.15397
- By:
- Publication type:
- Article
Integration of human inspection and artificial intelligence‐based morphological typing of patient‐derived organoids reveals interpatient heterogeneity of colorectal cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2693, doi. 10.1111/cas.15396
- By:
- Publication type:
- Article
Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2496, doi. 10.1111/cas.15390
- By:
- Publication type:
- Article
lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2681, doi. 10.1111/cas.15387
- By:
- Publication type:
- Article
miR‐3184‐3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2‐like macrophage polarization.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2668, doi. 10.1111/cas.15372
- By:
- Publication type:
- Article
LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple‐negative breast cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2484, doi. 10.1111/cas.15370
- By:
- Publication type:
- Article
CD44v3,8‐10 is essential for Slug‐dependent vimentin gene expression to acquire TGF‐β1‐induced tumor cell motility.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2654, doi. 10.1111/cas.15353
- By:
- Publication type:
- Article
Establishment of a monoclonal antibody against glycosylated CD271 specific for cancer cells in immunohistochemistry.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2878, doi. 10.1111/cas.15340
- By:
- Publication type:
- Article
In this issue: Volume 113, Issue 8, August 2022.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2481, doi. 10.1111/cas.14958
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2022, v. 113, n. 8, p. 2477, doi. 10.1111/cas.14957
- Publication type:
- Article